Alexandra Scrymgeour, PharmD

Aripiprazole is commonly prescribed as a next-step pharmacotherapy for treatment-resistant depression, but its cost-effectiveness as an adjunct to antidepressants is unknown. Read this article to learn how the cost-effectiveness...